Cart
sales@molnova.com
N-(4-benzamidobutyl)benzamide
CAS No. 1991-78-2
N-(4-benzamidobutyl)benzamide( ——— )
Catalog No. M39340 CAS No. 1991-78-2
N-(4-benzamidobutyl)benzamide
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-(4-benzamidobutyl)benzamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(4-benzamidobutyl)benzamide
-
DescriptionN-(4-benzamidobutyl)benzamide
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1991-78-2
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Uridine triphosphate
Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor.
-
Fezakinumab
Fezakinumab is a potent monoclonal antibody to interleukin-22 (IL-22). Fezakinumab can be used to study immune system diseases and inflammation-related conditions such as psoriasis, rheumatoid arthritis and atopic dermatitis.
-
Pseudoprotodioscin
1. Pseudoprotodioscin has moderate cytotoxicity.
